CIK 0001055726 · Non-accelerated filer<br>Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330969592
- Phone
- 8584103134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-15 | Humeau Laurent Chief Scientific Officer | Option exercise | +4,771 | 44,671 | ||
| 2026-05-15 | Humeau Laurent Chief Scientific Officer | Shares withheld for taxes | −1,712 | $1.30 | $2K | 42,959 |
| 2026-05-15 | Humeau Laurent Chief Scientific Officer | Option exercise · Restricted Stock Unit | −4,771 | 0 | ||
| 2026-05-15 | KIES PETER CFO | Option exercise | +4,771 | 41,413 | ||
| 2026-05-15 | KIES PETER CFO | Shares withheld for taxes | −2,571 | $1.30 | $3K | 38,842 |
| 2026-05-15 | KIES PETER CFO | Option exercise · Restricted Stock Unit | −4,771 | 0 | ||
| 2026-03-31 | Sumner Michael John Chief Medical Officer | Option exercise | +4,292 | 34,799 | ||
| 2026-03-31 | Sumner Michael John Chief Medical Officer | Shares withheld for taxes | −1,223 | $1.74 | $2K | 33,576 |
| 2026-03-31 | Sumner Michael John Chief Medical Officer | Option exercise · Restricted Stock Unit | −4,292 | 0 | ||
| 2026-03-04 | Sumner Michael John Chief Medical Officer | Grant or award · Common Stock Option | +36,832 | 36,832 | ||
| 2026-03-04 | Sumner Michael John Chief Medical Officer | Grant or award · Restricted Stock Unit | +29,608 | 29,608 | ||
| 2026-03-04 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Common Stock Option | +97,240 | 97,240 | ||
| 2026-03-04 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Restricted Stock Unit | +78,760 | 78,760 | ||
| 2026-03-04 | Humeau Laurent Chief Scientific Officer | Grant or award · Common Stock Option | +26,840 | 26,840 | ||
| 2026-03-04 | Humeau Laurent Chief Scientific Officer | Grant or award · Restricted Stock Unit | +21,560 | 21,560 | ||
| 2026-03-04 | KIES PETER CFO | Grant or award · Common Stock Option | +31,240 | 31,240 | ||
| 2026-03-04 | KIES PETER CFO | Grant or award · Restricted Stock Unit | +25,520 | 25,520 | ||
| 2026-02-26 | Sumner Michael John Chief Medical Officer | Option exercise | +5,010 | 22,860 | ||
| 2026-02-26 | Sumner Michael John Chief Medical Officer | Option exercise | +11,550 | 34,410 | ||
| 2026-02-26 | Sumner Michael John Chief Medical Officer | Shares withheld for taxes | −3,903 | $1.79 | $7K | 30,507 |
Page 3 of 17 · 322 trades